In 2009, the outlook for Eli Lilly was uncertain. But a dogged commitment to R&D has shored up its future and positioned it at the forefront of pharma innovation. Pursuing organic growth is often ...
All the latest news, trends, and developments, for up to 5 users. Exclusive interviews from leading entrepreneurs, FTSE 350 CEOs, thought leaders. MT Classroom - giving you an academic grounding ...
All the latest news, trends, and developments, for up to 5 users. Exclusive interviews from leading entrepreneurs, FTSE 350 CEOs, thought leaders. MT Classroom - giving you an academic grounding ...
All the latest news, trends, and developments, for up to 5 users. Exclusive interviews from leading entrepreneurs, FTSE 350 CEOs, thought leaders. MT Classroom - giving you an academic grounding ...
All the latest news, trends, and developments, for up to 5 users. Exclusive interviews from leading entrepreneurs, FTSE 350 CEOs, thought leaders. MT Classroom - giving you an academic grounding ...